Lakewood-Amedex Biotherapeutics Inc. (LABT) Operating income 2024–2025
Lakewood-Amedex Biotherapeutics Inc. (LABT) annual operating income history from SEC filings — each fiscal year as reported.
-$3.8MFY2025 · since FY2024: -$4.0M → -$3.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.8M | +6.3% |
| FY2024 | -$4.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice